Friday, 7 March 2008
Phase II
In Phase II mesothelioma clinical trials, the mesothelioma drug is studies in a larger group. The primary purpose of these studies is to see how well the drug or treatment shrinks tumors in patients with specific types of cancer. The investigator will watch closely for side effects and will also watch how the disease responds to the treatment.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment